Webinar: What's Next for Medicaid Drug Pricing? Thursday, February 27 | 12:30-1:30 PM ET 2020 Healthcare Outlook See the Turns Ahead Streaming Webinar Watch the Recording & Download the Document Value-Based CareLive Discharge Rates for Hospice Patients Vary by DiagnosisFederal Policy5 High Impact Areas in the MA Advance Notice & Proposed RuleFederal PolicyCMS Proposes Allowing Part D Plans to Implement a New Preferred Specialty Tier Federal PolicyFor the First Time, a Majority of Generic Drugs Are on Non-Generic Tiers in Part DVaccines / Preventive ServicesPreventive Care Commentary Featured in Health Affairs BlogSocial Determinants of HealthAddressing Social Determinants of Health Requires a Strategic Approach in an Evolving Healthcare EnvironmentDetails Matter: 2020 ElectionDetails Matter: Healthcare Coverage Landscape Varies in Early Primary StatesState PolicyCMS’s Healthy Adult Opportunity Program Includes Significant Changes to Medicaid Drug Benefit“Our partnership developed the first quality measures for older adults at risk of hypoglycemia.”Kristi MitchellPractice Director0Ways AI has significant impact in healthcareState PolicyWebinar: What's Next for Medicaid Drug Pricing?“Older, comorbid, DLBCL patients can successfully be treated with CAR T-cell therapy.”Karl KilgoreSenior Research Scientist0BAvalere estimated CMMI Medicare $ savings from 2017-2026 budgetFederal PolicyVariation in Generic Substitution Rates Among Part D Plans
